Frankfort—While Puma still expects an increase in full-year net income compared to 2012, the athletic footwear maker today posted a drop in sales and product in its second quarter earnings report.
Puma, which is 83% controlled by Kering, remains a distant No. 3 behind Nike and Adidas especially in athetlicwear sales. Its second quarter profit before interest and taxes fell to 31 million euros (about $40.9 million) from 47 million euros a year ago. The results also missed analysts’ average estimate for 36.1 million euros.
“Southern Europe and the Far East remain challenging,” Puma said. Revenue fell 4% to 692 million euros on a currency adjusted basis, missing the 709 million-euro average analysts estimated.
Those misses sent shares of the company down in trading earlier today and brought renewed hope that the new CEO Bjorn Gulden, a former Adidas executive and professional athlete, could bring back credibility to Puma as a sports brand rather than just a fashion brand.
Gross Margin Pressure
“I think we have the worst behind us, but if we look at the economic environment and what we’re getting from the markets, then we see that the second half will be quite challenging,” Michael Laemmermann, chief financial officer, said.
Besides cutting jobs and product ranges in footwear, Puma has closed stores and hopes to improve its performance-wear offerings.
Poor sales in France, Italy and China, and Japan—its second largest market with about 10% of total sales—and increased discounts narrowed Puma’s gross margin to 46% from 49.1%.
Sales in Asia-Pacific declined by 7.2%. Laemmermann said China remained tough, with an excess of stock on the market.
Footwear sales, which account for nearly 50% of total revenue, fell 7.3% in the quarter as the group had to discount its products more than last year to get them off the shelves. Puma’s footwear sales fell by 7.8% in the first quarter (Adidas increased its by 3 %.)
Puma had cut its fiscal full year forecast in May and reiterated it today: a low-to-mid single-digit decline in currency-adjusted sales as well as gross profit margin pressure during the second half. Total sales are expected to be up between 1% to 5%.
For commercial purposes, extract supplements can be obtained from the fruit of the pericarp. Garcinia cambogia reviews is performed by a physician Chen and Oz to prove that it is an herb for weight loss, a lot of research has been done. Studies, Garcinia cambogia extract supplementation decreases the weight of the body fat accumulation, was shown to have a positive effect on prevention. We are important substances such as cholesterol (LDL), reduces the serum leptin and triglycerides. In addition, it will increase the level of serotonin and cholesterol (HDL). The study also, Garcinia cambogia extract supplements, has proven that there are no significant adverse effects on many of the eight weeks, such as its use.